Comments

Mirum Pharmaceuticals Stock Guidance

MIRMNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$64.10

-0.90-1.38%

At close: Dec 15, 4:00 PM EST

$64.10

N/A

After Hours: 4:00 PM EST

Overview News Earnings Options

Guidance

Analyst Ratings Insider Trades Short Interest Stock Report

Mirum Pharmaceuticals Stock Guidance | NASDAQ:MIRM | Benzinga

Mirum Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/04/2025	MIRM	Mirum Pharmaceuticals	FY	2025	—	—	—	$500.00M	$510.00M	$507.38M	Get Alert
08/06/2025	MIRM	Mirum Pharmaceuticals	FY	2025	—	—	—	$490.00M	$510.00M	$453.21M	Get Alert
05/07/2025	MIRM	Mirum Pharmaceuticals	FY	2025	—	—	—	$435.00M	$450.00M	$427.77M	Get Alert
02/26/2025	MIRM	Mirum Pharmaceuticals	FY	2025	—	—	—	$420.00M	$435.00M	$425.47M	Get Alert
11/12/2024	MIRM	Mirum Pharmaceuticals	FY	2024	—	—	—	$330.00M	$335.00M	$316.22M	Get Alert
08/07/2024	MIRM	Mirum Pharmaceuticals	FY	2024	—	—	—	$310.00M	$320.00M	$312.97M	Get Alert
05/08/2024	MIRM	Mirum Pharmaceuticals	FY	2024	—	—	—	$310.00M	$320.00M	$317.24M	Get Alert
01/08/2024	MIRM	Mirum Pharmaceuticals	FY	2023	—	—	—	$186.00M	$188.00M	$185.40M	Get Alert
04/12/2023	MIRM	Mirum Pharmaceuticals	Q1	2023	—	—	—	$31.50M	$31.50M	$26.03M	Get Alert
11/09/2022	MIRM	Mirum Pharmaceuticals	FY	2022	—	—	—	$70.00M	$70.00M	$74.72M	Get Alert

FAQ

Q

What is the most recent guidance for Mirum Pharmaceuticals (MIRM)?

A

There have been no specific sales or earnings guidance reported for Mirum Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

IDEAYA Biosciences Inc

Legend Biotech Corp

Ultragenyx Pharmaceutical Inc

Centessa Pharmaceuticals PLC

Ascentage Pharma Group International

Arcutis Biotherapeutics Inc

Xenon Pharmaceuticals Inc

Viking Therapeutics Inc